The global men's reproductive health device market was valued at over $289 million in 2024 and is projected to grow at a CAGR of 2.5%, reaching over $343 million by 2031.
Market Segments Covered:
- Inflatable Erectile Dysfunction (ED) Devices
- Malleable Erectile Dysfunction Devices
Comprehensive Market Insights
- Market Size & Growth Trends
- Unit Sales & Average Selling Prices
- Market Drivers & Limiters
- Procedure Numbers
- Forecasts Until 2031 & Historical Data (2021-2023)
- Competitive Market Share Insights
- Recent Mergers & Acquisitions
- Company Profiles & Product Portfolios
Global Market Trends
- Erectile Dysfunction Prevalence: Strongly linked to Benign Prostatic Hyperplasia (BPH) and prostate cancer treatments.
- Treatment Patterns: ED caused by radiation therapy tends to develop later compared to radical prostatectomy (RP).
- Technological Advancements: Increasing innovation in inflatable and malleable penile prostheses.
Market Share Insights
Top Competitors in the Global Erectile Dysfunction Device Market (2024):
1 Boston Scientific
- Market leader offering the AMS 700™ MS Series (three-piece inflatable devices) and AMS Ambicor® (two-piece inflatable devices).
- Dominates the market following its 2018 acquisition of American Medical Systems (AMS).
2 Coloplast
- Second-largest competitor with the Titan® Inflatable Penile Prosthesis and Malleable Penile Prostheses.
3 Rigicon
- Newest entrant offering the Rigi10™ (malleable prosthesis) and Infla10® (inflatable prosthesis).
Market Segmentation Summary
- Inflatable Erectile Dysfunction Devices
- Malleable Erectile Dysfunction Devices
Global Research Scope
Report Details:
- Regions Covered:
- North America: U.S., Canada
- Latin America: Brazil, Mexico, Argentina, etc.
- Western Europe: U.K., Germany, France, Spain, Italy, etc.
- Central & Eastern Europe: Russia, Poland, Turkey, etc.
- Middle East: Saudi Arabia, UAE, Israel, etc.
- Asia Pacific: China, Japan, India, Australia, etc.
- Africa: South Africa, Nigeria, Egypt, etc.
- Base Year: 2024
- Forecast Period: 2025-2031
- Historical Data: 2021-2023
Quantitative Coverage:
- Market Size, Market Shares, Market Growth Rates
- Unit Sales & Average Selling Prices
Qualitative Coverage:
- COVID-19 Impact
- Market Growth Trends & Limiters
- Competitive Analysis & SWOT for Top Competitors
- Mergers & Acquisitions
- Company Profiles & Product Portfolios
- FDA Recalls & Disruptive Technologies
- Disease Overviews
Data Sources:
- Primary Interviews with Industry Leaders
- Government & Regulatory Data
- Hospital & Private Sector Data
- Import & Export Records
- Research Internal Database
Table of Contents
Men’s reproductive health Device Market
List of Charts
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Accu-Tech
- Caldera Medical
- Ackermann
- Cardinal Health
- Agency for Medical Innovations (A.M.I.)
- Casa Medica
- Allium Medical
- Centurion Medical Products
- Ambu
- Changzhou JIUHONG Medical Instrument
- Amecath
- Chengdu Yunke Pharmaceutical (Dongcheng)
- Americanas
- Coloplast
- Amsino
- Contura
- Angiodynamics
- ConvaTec
- Anhui Easyway Medical Supplies
- Convergent Laser Technologies
- Anjue Medical Equipment
- Cook Medical
- Apexmed International
- Create Medical
- Applied Medical
- CureStar
- AprioMed
- Degania Medical
- Argon Medical
- DeRoyal
- Axonics
- Dipher
- Bactiguard
- Direx
- BARD
- Direx Group
- Becton Dickinson
- Dornier MedTech
- Beijing Zhibo Hi-Tech
- Eckert & Ziegler BEBIG
- Best Medical
- EDAP TMS
- BioDerm
- Electro Medical Systems
- Biolitec
- Elekta
- Biosat
- Endocure
- Bonro Medical
- Endo Personal Care
- Boston Scientific
- Envaste Medical
- BR Surgical
- Ethicon
- BXTAccelyon
- FEG Textiltechnik
- Calcula Technologies
- Forlong Medical
